🇺🇸 FDA
Patent

US 8062643

Use of neurotoxin therapy for treatment of urologic and related disorders

granted A61KA61K31/16A61K31/353

Quick answer

US patent 8062643 (Use of neurotoxin therapy for treatment of urologic and related disorders) held by The Regents of the University of Colorado expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/16, A61K31/353, A61K38/4893, A61P